Aktis Oncology, Inc. · NASDAQ:AKTS
Czibere Akos sold 12,500 Aktis Oncology, Inc. shares (Form 4)
Traded Sep 23, 2026 · Filed Sep 24, 2026
On Sep 23, 2026, Czibere Akos (Chief Medical Officer) sold 12,500 Aktis Oncology, Inc. shares at an average US$20.69 for US$259K under a trading plan, leaving 0 shares. Filed Sep 24, 2026 (Form 4).
- Sold
- 12,500 shares
- Price
- US$20.69 average (US$20.19 to US$21.03)
- Value
- US$259K
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | Common Stock | Option exercise | 12,500 | US$4.95 | 12,500 | Direct |
| Sep 23, 2026 | Common Stock | Sale | 5,099 | US$20.19 | 7,401 | Direct |
| Sep 23, 2026 | Common Stock | Sale | 7,401 | US$21.03 | 0 | Direct |
Source
Related
- Aktis Oncology, Inc.
- Czibere Akos
- Aktis Oncology, Inc. shareholders
- Form 4 · Czibere Akos · Jul 10, 2026
- Form 4 · Herrmann Ken · Jul 21, 2026
- Form 4 · Herrmann Ken · Jul 20, 2026
- Form 4 · Ron-Bigger Shulamit · Jul 10, 2026
- Schedule 13G · Blue Owl Capital Holdings LP · May 14, 2026
- Schedule 13D · EcoR1 Capital, LLC · Jan 20, 2026